Skip to content Site Search

Menu

Home

We’re an independent, nonprofit newsroom reporting on gender, politics, policy and power. Read our story.

Topics

  • Politics
  • LGBTQ+
  • Health
  • Justice
  • Caregiving
  • Education
  • Abortion
View all topics

Daily Newsletter

Your trusted source for contextualizing the latest election news.

Look for a confirmation sent to

Did you mean

The email didn't go through.

or Contact us for support
  • Latest Stories
  • Our Mission
  • Our Team
  • Strategic Plan
  • Support the 19th
  • Search
  • Contact
Donate

Republish This Story

* Please read before republishing *

We’re happy to make this story available to republish for free under an Attribution-NonCommercial-NoDerivatives Creative Commons license as long as you follow our republishing guidelines, which require that you credit The 19th and retain our pixel. See our full guidelines for more information.

To republish, simply copy the HTML at right, which includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to The 19th. Have questions? Please email partnerships@19thnews.org.

— The Editors

Loading...

Modal Gallery

/
Home

We’re an independent, nonprofit newsroom reporting on gender, politics, policy and power. Read our story.

Daily Newsletter

Your trusted source for contextualizing the latest election news.

Look for a confirmation sent to

Did you mean

The email didn't go through.

or Contact us for support

Become a member

We’re an independent, nonprofit newsroom reporting on gender, politics, policy and power. Read our story.

Two speech bubbles, one with an outlined border and one with a lilac fill.

Make sense of the midterms

Get through election week with our daily newsletter covering the women and queer people still fighting to be seen and heard in our democracy.

Subscribe Now

The 19th thanks our sponsors. Become one.

LGBTQ+

DOJ, HHS, FTC, FDA: The alphabet soup of efforts to restrict gender-affirming care

Dozens of investigations, subpoenas and lawsuits are bearing down on families of trans youth and hospitals providing the care.

Graphic illustration of dark columns receding into the background, with layered blue, pink and white bands of the transgender pride flag cutting across the shadows of the columns.
Youth transition care is banned in 27 states, according to KFF, a nonpartisan health policy organization — and 24 states impose penalties against healthcare practitioners who provide it. (Emily Scherer for The 19th/Getty Images)

Orion Rummler

LGBTQ+ Reporter

Published

2026-07-06 05:00
5:00
July 6, 2026
am
America/Chicago

Updated

2026-08-17 16:57:00.000000
America/New_York

Share

  • Bluesky
  • Facebook
  • Reddit
  • Email

The United States is using the full power of the federal government to restrict gender-affirming care for transgender youth. 

The American Psychological Association has accused the Trump administration of ignoring science and undermining mental health through its anti-trans policies. Groups including Planned Parenthood, AIDS United and the Human Rights Campaign see these tactics as a serious threat to the private medical information of everyone, not just trans people. If doctors can’t provide treatment without fear of political retaliation, these advocacy groups say, public health will be harmed. 

In response to pressure from the administration, many hospitals across the country have stopped seeing young trans patients, including some in states where gender-affirming care is protected.

The 19th thanks our sponsors. Become one.

Youth transition care is banned in 27 states, according to KFF, a nonpartisan health policy organization — and 24 states impose penalties against healthcare practitioners who provide it. Half of trans teenagers in the United States live in states where care is already banned, per the Williams Institute at the UCLA School of Law. 

As a reminder, gender-affirming care in a medical setting means taking puberty blockers as a preteen, hormone therapy as a teenager, or, for a small minority of transgender youth, surgery. Not all trans youth pursue all of these treatments. 

We break down how federal agencies are taking unprecedented action to keep physicians from providing the care and what’s coming next. 

The Department of Health and Human Services 

The agency in August finalized a policy to bar federal Medicaid and Children’s Health Insurance Program (CHIP) funds from covering gender-affirming care for trans youth. The rule would still allow states to use their own funds to cover trans health care, however. 

The policy grants a “tapering period” for youth on hormone therapy, which would extend federal coverage for six months after the rule takes effect. It is expected to go into effect in October, although lawsuits could halt the rule before it takes place. The Massachusetts attorney general’s office plans to sue. 

Ultimately, this rule will impact low-income families, said Lindsey Dawson, director of LGBTQ health policy at KFF. It doesn’t bar providers from offering gender-affirming care, but it does create a cost barrier for low-income people, she said. 

The day after this policy was finalized, HHS Secretary Robert F. Kennedy Jr. called for the agency’s inspector general to investigate hundreds of hospitals and clinics that have provided gender-affirming care to trans youth. This is part of the administration’s broader strategy to portray the care as fraud, Dawson said. 

Throughout this year, HHS General Counsel Mike Stuart has referred many children’s hospitals to the agency’s inspector general — but these investigations don’t really have teeth, experts say. 

“It’s an announcement made for the purpose of intimidating providers, clinics and hospitals,” said Jennifer Levi, senior director of transgender and queer rights at GLBTQ Legal Advocates & Defenders, or GLAD. Regardless, in response to a lawsuit, the agency agreed to pause potential punitive action against those hospitals.

In many cases, the administration’s attempts to intimidate hospitals from providing gender-affirming care to minors is working. Hospitals in blue states like Massachusetts and New York have halted care — even after judges sided with their states against the Trump administration. Families are left to find alternatives in states where, according to state law, gender-affirming care is still legal.

HHS has stopped short of moving ahead with a proposal to withhold all federal funds from hospitals that provide trans youth care, which would force providers to stop offering the care altogether.

But that dropped policy does not mean the agency is slowing down. HHS just released a wide-ranging report accusing hospitals of profiting off of gender-affirming care, which Vice President JD Vance has used to press the Justice Department to take action. 

The Justice Department

For over a year, the Department of Justice (DOJ) has been investigating whether off-label promotion or dispensing of puberty blockers and hormones for trans minors violated federal law, like the Food, Drug, and Cosmetic Act (FDCA).

As part of that investigation, the DOJ has tried to force hospitals to share names of patients under 18 who have received gender-affirming care in the past five to seven years, plus names of staff who provided the care. The agency is also digging for internal hospital emails, social media metadata (which includes timestamps and location), and any exchanges with pharmaceutical companies making puberty blockers or hormones. 

More from The 19th

  • The 19th Explains: Everything you need to know about gender-affirming care
    A transfeminine person speaks to a therapist in an office.
  • The government’s fight against gender-affirming care just escalated
  • How gender-affirming care is becoming a political test for top medical groups

The DOJ has sent dozens of civil subpoenas to hospitals across the country seeking this information.

Now, the department has escalated this effort through a federal criminal investigation into gender-affirming care. At least three hospitals have received grand jury subpoenas for years of data on adolescent patients: NYU Langone Hospitals and the Mount Sinai Health System in New York City, plus the Lucile Packard Children’s Hospital at Stanford. Two federal judges have halted these efforts; most recently, a judge in early July halted the government from accessing private medical records of minors who received gender-affirming care at the Stanford children’s hospital.

U.S. District Judge Katherine Failla, who blocked the grand jury subpoena into NYU Langone in late June, said the agency’s request “shocks the conscience.”

Many judges have come to similar conclusions. 

At least eight federal district courts have blocked or limited civil subpoenas, according to an analysis from researchers at the O’Neill Institute at Georgetown Law. Judges have rebuked the agency for hitting hospitals with overbroad demands for patient data in states where this health care is legal. 

The Justice Department has appealed in a bid to enforce civil subpoenas. 

“A lot of the litigation has, importantly, protected patient records,” said Katie Keith, director of the center for health policy and the law at the Georgetown institute. “So far, to date, these court cases have been working.” 

But not every hospital sued in response to the government’s demands. Without the paper trail of a lawsuit, researchers don’t know if some patient information has exchanged hands. 

Several hospitals have settled with the DOJ. The Cleveland Clinic in Ohio agreed to pay $308,000 to resolve allegations of false billing to insurance companies for minors’ gender-affirming care. The clinic also committed $2 million to restorative care for detransitioners, people who sought a gender transition and then halted or reversed aspects of it. Texas Children’s Hospital will pay $10 million to resolve false billing allegations and plans to open a clinic for detransitioners.

As the agency pursues its investigation, judges are nervous about what the DOJ plans to do with the private medical information of patients that it’s seeking.

In the case involving NYU Langone, Failla said the DOJ had not assured her about how the medical data would be used or that parents of trans youth would not be punished, per the New York Times. During a hearing in late June, a Justice Department lawyer only said that young patients would not be prosecuted.

The Federal Trade Commission

The Federal Trade Commission (FTC) is meant to operate independently of the White House, but the Trump administration has taken steps to sever that independence. Now, targeting gender-affirming care is a priority for the agency, whose job is to protect Americans from deceptive business practices. 

In June, the agency sued the World Professional Association for Transgender Health (WPATH), which sets global standards for doctors and nurses treating transgender patients. The FTC accuses WPATH of enabling medical providers to make “false and unsubstantiated claims to parents in order to sell pediatric medical transition services.” 

Four states — Alaska, Iowa, Nebraska and Texas — joined the lawsuit alongside the FTC. The complaint was filed in the U.S. District Court for the Northern District of Texas.

Previously, the agency made sweeping demands for internal communications from WPATH, as well as two other nonprofit medical groups that endorse gender-affirming care. The FTC wanted up to a decade of documents from the Endocrine Society, plus information on who at the American Academy of Pediatrics had developed clinical guidance on gender-affirming care. 

A federal judge blocked the probes into the Endocrine Society and American Academy of Pediatrics, finding them to be a potential threat to free speech under the First Amendment. The FTC dropped them after it sued WPATH, saying that information from the two medical groups was no longer necessary. 

It’s an extreme step to target medical professional associations with investigative demands like this, said Jennifer Levi, senior director of transgender and queer rights at GLBTQ Legal Advocates & Defenders, or GLAD. The group is involved in several lawsuits against the Trump administration. 

The Food and Drug Administration 

The FDA has threatened 12 manufacturers and retailers selling chest binders, which are worn by trans men and nonbinary people to manage gender dysphoria. It has warned them that the binders are medical devices that must be registered with the FDA, according to the Food, Drug and Cosmetic Act.

It is rare for the FDA to send letters like this for low-risk products and even rarer for the agency to issue this kind of warning over a procedural issue as small as failing to register a product, experts say.

The agency has threatened enforcement action like import alerts, seizures and injunctions if “illegal marketing of these products for children” continues. None of the warning letters sent to companies mention selling binders to minors, or list any health risks associated with wearing them. And so far, all of the companies that received warning letters from the FDA in December are still selling chest binders.

Share

  • Bluesky
  • Facebook
  • Reddit
  • Email

Recommended for you

  • A person with pink and purple hair raises both arms while dancing among a crowd of smiling and clapping protesters at the Texas State Capitol. A person beside them with purple braids and a pink skirt laughs and dances.
    Most trans people who started hormones as teens say it was the right decision, study finds
  • An illustrative image depicting words from a federal report on gender ideology and left-wing authoratarianism.
    What Trump’s new study says about support for trans rights — and why experts are worried
  • Trans kids are vulnerable to eating disorders. This therapist knows what they’re going through.
  • Pam Bondi speaks at a Justice Department podium in the foreground as Todd Blanche stands behind her, framed by American and departmental flags.
    What Trump’s AG pick has said about LGBTQ+ rights, abortion and the Epstein files

Daily Newsletter

Your trusted source for contextualizing the latest election news.

Look for a confirmation sent to

Did you mean

The email didn't go through.

or Contact us for support

Become a member

Explore more coverage from The 19th

  • Politics
  • LGBTQ+
  • Health
  • Justice
  • Caregiving
View all topics

Site Footer

Support representative journalism today.

Learn more about membership.

  • Give $19
  • Give $50
  • Give $100
  • Any amount

Transparency

  • About
  • Team
  • Contact
  • Privacy Policy
  • Community Guidelines
  • Gift Acceptance Policy
  • Financials

Newsroom

  • Latest Stories
  • Strategic Plan
  • 19th News Network
  • Events
  • Careers
  • Fellowships

Newsletters

  • Daily
  • The Amendment
  • Menopause
  • The Mom Guilt Economy
  • View all

Support

  • Ways to Give
  • Sponsorship
  • Republishing
  • Volunteer
  • Merch

The 19th is a reader-supported nonprofit news organization. Our stories are free to republish with these guidelines.